Document is current
Any future updates will be listed below
-
Authors
Massy, Marine https://orcid.org/0009-0006-4282-8609
Marti, Stefanie https://orcid.org/0000-0001-8237-6965
Hammer, Helly
Hoepner, Robert https://orcid.org/0000-0002-0115-7021
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 21 March 2025
First Online: 7 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: Massy M reports no competing interests. Marti S reports no competing interests. Hammer H received research support and travel grants within the last 5 years from Biogen, Merck, Roche & Bristol Myers Squibb, Teva, Johnson&Johnson, Novartis. All not related to that work. Hoepner R received speaker/advisor honorary from Merck, Novartis, Roche, Biogen, Alexion, Sanofi, Janssen, Bristol-Myers Squibb, Teva/Mepha and Almirall. He received research support within the last 5 years from Roche, Merck, Sanofi, Biogen, Chiesi, and Bristol-Myers Squibb. He also received research grants from the Swiss MS Society, the SITEM Insel Support Fund and is a member of the Advisory Board of the Swiss and International MS Society. He also serves as deputy editor in chief for Journal of Central Nervous System disease and is part of the ECTRIMS Young Investigator Committee.
